Type I Gaucher Disease Following Chemotherapy for Light Chain Multiple Myeloma

スポンサーリンク

概要

• 論文の詳細を見る

• Although plasma cell disorders, such as hypergammaglobulinemia and monoclonal gammopathy of undetermined significance (MGUS), are reported to occur at higher incidences in patients with Type I Gaucher disease (GD) than in the normal population, pure light chain multiple myeloma (LCMM) has never been described in this context. Our case is the first to highlight a patient with LCMM who developed clinically apparent GD only following chemotherapy and hematopoietic stem cell transplantation. Renal complications are also exceedingly rare in GD, but nephrotic syndrome is one of the presenting features in this patient. The findings from this case will have important screening and diagnostic implications for both clinicians and patients.

• 社団法人 日本内科学会の論文

著者

• Greenberg Cheryl

  Department Of Biochemistry And Medical Genetics University Of Manitoba

• Cheung Winson

  Department of Internal Medicine, University of Manitoba, Winnipeg

• Bernstein Keevin

  Department of Internal Medicine, University of Manitoba, Winnipeg

• Schacter Brent

  Cancer Care Manitoba, University of Manitoba, Winnipeg

• Fourie Thomas

  Pathology, University of Manitoba, Winnipeg

• Seftel Matthew

  Department of Internal Medicine, University of Manitoba, Winnipeg

関連論文

• Agenesis of the corpus callosum and cerebral anomalies in inborn errors of metabolism
• Type I Gaucher Disease Following Chemotherapy for Light Chain Multiple Myeloma

スポンサーリンク